These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1879060

  • 1. d-fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration.
    O'Keane V, O'Hanlon M, Webb M, Dinan T.
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):289-92. PubMed ID: 1879060
    [Abstract] [Full Text] [Related]

  • 2. Effect of pindolol on the prolactin response to d-fenfluramine.
    Park SB, Cowen PJ.
    Psychopharmacology (Berl); 1995 Apr; 118(4):471-4. PubMed ID: 7568634
    [Abstract] [Full Text] [Related]

  • 3. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes.
    Monteleone P, Brambilla F, Bortolotti F, Ferraro C, Maj M.
    Psychol Med; 1998 Jul; 28(4):975-83. PubMed ID: 9723152
    [Abstract] [Full Text] [Related]

  • 4. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
    Monteleone P, La Rocca A, Fuschino A, Bortolotti F, Maj M.
    Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
    [Abstract] [Full Text] [Related]

  • 5. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H, Sjögren M, Agren H.
    J Affect Disord; 2000 Feb; 57(1-3):201-8. PubMed ID: 10708832
    [Abstract] [Full Text] [Related]

  • 6. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT, Hershman JM, Boyd AE, Longcope C, Bacharach P.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [Abstract] [Full Text] [Related]

  • 7. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
    Ramasubbu R, Flint A, Brown G, Awad G, Kennedy S.
    Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
    [Abstract] [Full Text] [Related]

  • 8. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function.
    O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG.
    Br J Psychiatry; 1992 May; 160():643-6. PubMed ID: 1591573
    [Abstract] [Full Text] [Related]

  • 9. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA, Sherman BM.
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
    Baumann MH, Ayestas MA, Rothman RB.
    Ann N Y Acad Sci; 1998 May 30; 844():138-52. PubMed ID: 9668672
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant?
    Steiner M, Yatham LN, Coote M, Wilkins A, Lepage P.
    Psychiatry Res; 1999 Oct 11; 87(2-3):107-15. PubMed ID: 10579544
    [Abstract] [Full Text] [Related]

  • 13. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R, Flint A, Brown G, Awad G, Kennedy S.
    Stroke; 1998 Jul 11; 29(7):1293-8. PubMed ID: 9660375
    [Abstract] [Full Text] [Related]

  • 14. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V, McLoughlin D, Dinan TG.
    J Affect Disord; 1992 Nov 11; 26(3):143-50. PubMed ID: 1460163
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone and prolactin response to ghrelin during the normal menstrual cycle.
    Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE.
    Clin Endocrinol (Oxf); 2009 Sep 11; 71(3):383-7. PubMed ID: 19094072
    [Abstract] [Full Text] [Related]

  • 16. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF, Kavoussi RJ, Cooper TB, Hauger R.
    Psychopharmacology (Berl); 1998 Jul 11; 138(1):9-15. PubMed ID: 9694521
    [Abstract] [Full Text] [Related]

  • 17. Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine.
    Quattrone A, Tedeschi G, Aguglia U, Scopacasa F, Direnzo GF, Annunziato L.
    Br J Clin Pharmacol; 1983 Nov 11; 16(5):471-5. PubMed ID: 6639832
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF, Kavoussi RJ, Cooper TB, Hauger R.
    Psychopharmacology (Berl); 1996 Sep 11; 127(2):108-12. PubMed ID: 8888375
    [Abstract] [Full Text] [Related]

  • 20. Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA.
    Poland RE, Lutchmansingh P, McCracken JT, Zhao JP, Brammer GL, Grob CS, Boone KB, Pechnick RN.
    Psychopharmacology (Berl); 1997 Jun 11; 131(4):411-9. PubMed ID: 9226745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.